|
|
|
|
Cure Entrepreneur BlogMarch 27, 2012 The Learning Collaborative, a partnership between the Leukemia & Lymphoma Society (LLS), University of Kansas Cancer Center, and the National Center for Advancing Translational Sciences (NCATS) at NIH, is attempting to break the traditional drug discovery and development paradigm by bringing together blood cancer, drug discovery, and development expertise across several organizations. The Collaborative was formed with the goal of targeting repurposed drugs as well as novel, new drugs for the treatment of rare blood cancers.
Jan. 6, 2012 Top 10 Medical Research Trends to Watch in 2012 This year's version of FasterCures' annual list features NCATS, FDA, reimbursement, intellectual property, and more.
Dec. 20, 2011 Value of Establishing the NIH Center on Advancing Translational Sciences to Patients The spending bill President Barack Obama is expected to sign into law later this week will establish the National Center for Advancing Translational Sciences at the National Institutes of Health. The inclusion of funding for this initiative bodes well for our nation's medical research and development enterprise and for millions of patients who need new treatments and cures now.
| ||||||||||||||||||||
|